10 studies found for:    e1411
Show Display Options
Rank Status Study
1 Recruiting Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Conditions: Lymphoma;   Neurotoxicity;   Therapy-related Toxicity
Interventions: Biological: rituximab;   Drug: bendamustine hydrochloride;   Drug: bortezomib;   Drug: lenalidomide
2 Recruiting Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
Conditions: AML;   Adult
Intervention: Other: Observation
3 Recruiting Window of Opportunity Trial of ADXS 11-001 Vaccination Prior to Robotic Surgery of HPV-Positive Oropharyngeal Cancer
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma of the Head and Neck;   Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma
Intervention: Biological: ADXS11-001 (ADXS-HPV)
4 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2
5 Completed
Has Results
Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women
Condition: Vasomotor Symptoms
Interventions: Drug: desvenlafaxine succinate (DVS) SR;   Drug: Placebo
6 Completed
Has Results
Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study
Condition: Contraception
Interventions: Drug: LCS12;   Drug: LCS16
7 Completed
Has Results
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
8 Completed To Assess the Long-term Safety, Efficacy and Tolerability of Inhaled Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
9 Completed
Has Results
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium bromide;   Drug: Salmeterol;   Drug: Placebo Salmeterol;   Drug: Placebo Tiotropium
10 Recruiting BMN-673 and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies
Conditions: Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: PARP inhibitor BMN-673;   Drug: temozolomide;   Other: laboratory biomarker analysis;   Other: pharmacological study

Indicates status has not been verified in more than two years